Skip to main content

Closed

FULC: Fulcrum Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-30.4%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio31.35×

Fulcrum Therapeutics, Inc.

FULCNASDAQ Global Market·USD·Closed

Fulcrum Therapeutics, Inc.

FULCNASDAQ·USD·Closed

$3.58

−3.76%

$3.58

−$0.14 (3.76%)

52W Range

6thpctl

Volume

1.41×avg

Mkt Cap

193.72MUSD

P/E

-3.0TTM

Div Yield

–ann

52W Range

6thpctl

Volume

1.41×avg

Market Cap

193.72MUSD

P/E Ratio

-3.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings